Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib

Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Cancer Genetics and Cytogenetics - Volume 189, Issue 1, February 2009, Pages 63-67

Philippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, Tim H. Bruemmendorf, Ulrike Bacher, Axel R. Zander, Susanne Schnittger, Andreas Hochhaus,